Feb 4 • 12:32 UTC 🇪🇸 Spain elDiario.es

Novo Nordisk crashes in stock market after lowering sales forecast for Ozempic, its star drug

Danish pharmaceutical company Novo Nordisk's stock plummeted up to 17% in Copenhagen after it lowered sales and profit forecasts for 2026 due to increased competition for its flagship drug, Ozempic.

📡 Similar Coverage